News
December 15, 2025: A Massachusetts man will plead to giving botulism-causing injections, says the U.S. Attorney’s Office
The med spa owner admitted to using unapproved injectables that sickened at least 10 patients. New York authorities announced the results of a 2024 crackdown on illegal med spas. PSM published in The Journal of Illicit Trade, Financial Crime, and Compliance.
[...]PSM urges the House Energy & Commerce Committee to support the SAFE Drugs Act of 2025
PSM wrote the House Energy & Commerce Committee in support of the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act, to help protect the American drug supply from unsafely compounded medication.
[...]December 7, 2025: FDA seized more fake Ozempic pens in the U.S. supply chain
FDA announced the seizure of dozens of counterfeit Ozempic 1mg injection pens labeled with an authentic lot number, PAR1229, but displaying the expiration and lot numbers for the product in the wrong place.
[...]FDA Alert: More Counterfeit Ozempic found in U.S. Supply Chain
The FDA and Novo Nordisk are warning the public about counterfeit Ozempic injections circulating in the legitimate U.S. drug supply chain. The FDA announced the seizure of multiple batches of counterfeit Ozempic 1 mg injections, labeled with lot number PAR1229, on December 5, 2025. Their contents and safety are unverified and pose serious health risks.
[...]December 1, 2025: More botulism cases underscore the need for regulated, supervised Botox use
MMWR field notes about Americans hospitalized after self-injecting imported Botox raise serious concerns about patient safety.
[...]November 24, 2025: Surveys examine online pharmacy use and patients’ perceived safety
Surveys document consumer behaviors when purchasing medication from online pharmacies, finding that the public may not be aware of the dangers of IOPs.
[...]Five takeaways from CNBC’s investigation of alternative funding programs
What are the most important lessons from CNBC’s documentary about alternative funding programs (AFPs)?
[...]November 17, 2025: CNBC explores “alternative funding programs” forcing U.S. patients to take unregulated medicines
CNBC aired a documentary about alternative funding programs that included interviews with PSM’s Shabbir Imber Safdar, HSI and FDA officials, as well as a representative from Gilead Sciences and from the companies supplying these drug.
[...]November 10, 2025: FDA cracks down on sites supplying unapproved “Botox”
The FDA warned websites in five countries to stop selling Americans unapproved cosmetic injections.
[...]PSM asks House Energy & Commerce Committee to oppose H.R. 5316, The Drug Shortage Compounding Patient Access Act
PSM sent a letter explaining how H.R. 5316 undermines critical patient safety protections.
[...]